Literature DB >> 153335

Lymphocyte transformation test in leprosy: decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment.

W R Faber, D L Leiker, I M Nengerman, W P Zeijlemaker, P T Schellekens.   

Abstract

Untreated leprosy patients were examined with respect to lymphocyte transformation in vitro after stimulation with mycobacterial and other microbial antigens, allogeneic lymphocytes, or nonspecific mitogens. Methods were used to circumvent technical variability. The results were compared with those obtained in controls matched for age, sex, race, and environment. No evidence was found for a generalized impairment of lymphocyte transformation in vitro, whereas a specific defect towards Mycobacterium leprae was demonstrable in lepromatous leprosy patients. The response to M. leprae, investigated in untreated and treated leprosy patients, decreased along the leprosy spectrum. Moreover, the results of the one-way mixed lymphocyte cultures showed that lymphocytes from leprosy patients had a normal stimulator and responder capacity, when they were tested against a panel of allogeneic lymphocytes. The influence of serum factors was investigated in untreated leprosy patients in the mixed lymphocyte culture. On average, tuberculoid as well as lepromatous sera showed a low-level depressive effect, but some sera showed a stimulatory effect. Therefore, a depressive effect of serum factors cannot be considered to be a general feature of leprosy. The correlation between the Mitsuda type of lepromin skin test and the lymphocyte reactivity in vitro to M. leprae was studied, and a positive correlation was found.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153335      PMCID: PMC422209          DOI: 10.1128/iai.22.3.649-656.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Immunologic responses in patients with lepromatous leprosy.

Authors:  T H Rea; F P Quismorio; B Harding; K M Nies; P J Di Saia; N E Levan; G J Friou
Journal:  Arch Dermatol       Date:  1976-06

3.  The influence of leprosy on delayed-type skin reactions and serum agglutination titers to Candida albicans. A comparative study of patients with lepromatous and tuberculoid leprosy and controls in Ethiopia.

Authors:  A A BUCK; H F HASENCLEVER
Journal:  Am J Hyg       Date:  1963-05

4.  In vitro reactivity of human lymphocytes after cryopreservation using a programmed cooling device.

Authors:  M J Du Bois; P T Schellekens; J J De Wit; V P Eijsvoogel
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

5.  Impaired delayed hypersensitivity in patients with lepromatous leprosy.

Authors:  D S Waldorf; J N Sheagren; J R Trautman; J B Block
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

6.  Immunologic reactivity in patients with leprosy.

Authors:  J N Sheagren; J B Block; J R Trautman; S M Wolff
Journal:  Ann Intern Med       Date:  1969-02       Impact factor: 25.391

7.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

8.  The immunological consequences of antigen overload in experimental mycobacterial infections of mice.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load.

Authors:  I Nath; J Curtis; A K Sharma; G P Talwar
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

10.  Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

Authors:  D S Nelson; J M Penrose; M F Waters; J M Pearson; M Nelson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

View more
  6 in total

1.  Cytogenetic studies in leprosy patients before and after chemotherapy.

Authors:  D D'Souza; B C Das; I M Thomas
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

2.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

3.  Immune mechanisms in congenital cytomegalovirus infection: activation of CMV-specific T helper cells (CMV-Th) by exogenous IL-2.

Authors:  R C Gehrz; E S Peterson; Y N Liu
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

4.  Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.

Authors:  M D Sasiain; S de la Barrera; R Valdez; L M Balina
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

5.  Defective production of monocyte-activating cytokines in lepromatous leprosy.

Authors:  M A Horwitz; W R Levis; Z A Cohn
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

6.  Protein tyrosine phosphatase non-receptor type 22 gene polymorphism C1858T is not associated with leprosy in Azerbaijan, Northwest Iran.

Authors:  Mohammad Reza Aliparasti; Shohreh Almasi; Jafar Majidi; Fatemeh Zamani; Ali Reza Khoramifar; Ali Reza Farshi Azari
Journal:  Indian J Hum Genet       Date:  2013-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.